A unique vaccine
technology
Mymetics is the global leader in know-how and research for virosome based vaccines.
A rich and validated
pipeline
Multiple vaccine candidates and high value partnerships and collaboration with some of the world’s leading research funding organizations.
Prevention with
innovative science
Developing new generation of vaccines by blocking the virus at the mucosal and serum level, the main gateways of human infections.
The world needs
many more vaccines
Only 26 diseases are addressed by vaccines in the world today. Our technology could be a tremendous asset to develop the next-generation vaccines and immunotherapies.
About us
More than 30 years of experience in the field of virosome vaccines, a unique R&D expertise, and intellectual property rights, makes Mymetics the global leader in this field. A focused strategy based on a sound scientific approach have resulted in the development a rich pipeline of vaccine candidates...
Read moreTechnology
Few companies in the world have developed such a powerful technology platform and a unique know-how to develop next-generation vaccines and immunotherapies for infectious and life disabling diseases...
Read moreVaccines
Key Partnership
Our virosome vaccine technology and know-how has been validated through high value partnerships and collaboration with some of the world’s leading research funding organizations.
Read moreMedia Center
Mymetics Corporation is a US registered biotechnology company with its main office in Switzerland and a R&D laboratory in the Netherlands. Mymetics’ vision is to become the market leader in the development of new generation virosomes based vaccines and immunotherapies for infectious and life disabling diseases.
Read moreSocial media
Follow Us